Journals / İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2018 / Cilt: 22 - Sayı: 2

THE RELATIONSHIP BETWEEN RENAL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

OTOZOMAL DOMİNANT POLİKİSTİK BÖBREK HASTALIĞI HASTALARINDA RENAL VE KARDİYOVASKÜLER OLAYLARIN İLİŞKİSİ

Pages
49–57
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion:In ADPKD patients, the increased TKV values and reduced renal function tests are associated with LVH and atherosclerosis development.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction:Autosomal dominant polycystic kidney disease (ODPBH) is a genetic disorder characterized by the development of multiple cysts in the bilateral kidneys.
📊
Key Findings & Data:Material and Methods:86 (36(41,9%) male) ADPKD patients were included in this cross-sectional study.
💡
Conclusion & Impact:Conclusion:In ADPKD patients, the increased TKV values and reduced renal function tests are associated with LVH and atherosclerosis development.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction:Autosomal dominant polycystic kidney disease (ODPBH) is a genetic disorder characterized by the development of multiple cysts in the bilateral kidneys. Cardiovascular events are the most common cause of mortality and morbidity. The aim of our study is to examine the relation between renal structure and renal function, and the development of LV hypertrophy (LVH) and atherosclerosis in adult ADPKD patients with predialysis chronic renal failure (CKD) and preserved left ventricular (LV) systolic function. Material and Methods:86 (36(41,9%) male) ADPKD patients were included in this cross-sectional study. The patients were compared to 47 healthy volunteer control group with similar age and gender distribution. Total kidney volume (TKV) and total cyst volume measurements were determined by non-contrast abdominal magnetic resonance imaging (MRI). With echocardiography, SV ejection fraction (LVEF), left atrial diameter (LAD), LV end- diastolic diameter (LVEDD), LV end-systolic diameter (LVESD) were calculated. Development of atherosclerosis was assessed with carotid artery intima-media thickness (CA-IMT) measurement. Results: According to the stage of CKD, 46 (53.5%) patients had stage 1-2 disease, 32 (37.2%) had stage 3-4 disease and 8 (9.3%) had predialysis stage 5 disease.56 patients (65.1%) were hypertensive. LVH was detected in 36 (41.9%) patients. In comparison to patients with predialysis stage 5 CKD, patients with stage 1-2 disease had higher eGFR and lower creatinine, TKV, UPCR, LVMI, and CA-IMT values.Patients with TKV>1302mm 3 showed higher values of creatinine (p=0.004), LVMİ (p=0.001), LVH (p=0.009) and CA-IMT (p=0.022), and lower values of eGFR (p=0.006) in compared to the patients with TKV ≤1302 mm 3 . Conclusion:In ADPKD patients, the increased TKV values and reduced renal function tests are associated with LVH and atherosclerosis development.

Özet

Giriş: Otozomal dominant polikistik böbrek hastalığı (ODPBH) bilateral böbreklerdeki çok sayıdaki kistlerin gelişimi ile karekterize genetik bir hastalıktır. Mortalite ve morbiditenin en sık nedeni kardiyovasküler olaylardır. Çalışmamızın amacı; sol ventrikül (SV) sistolik fonksiyonu korunmuş prediyaliz farklı kronik böbrek hastalığı (KBH) evrelerindeki erişkin ODPBH hastalarında; renal yapı ve renal fonksiyon ile SV hipertrofisi (SVH) ve ateroskleroz gelişimi arasındaki ilişkiyi incelemektir. Gereç ve Yöntem: Bu kesitsel çalışmaya 86 (36(%41.9) erkek) ODBPH hastası alındı. Hastalar yaş ve cinsiyet benzer 47 sağlıklı gönüllü kontrol grubu ile karşılaştırıldı. Toplam böbrek hacmi (TBH) ve toplam kist hacmi (TKH) ölçümleri kontrastsız üst batın manyetik rezonans görüntüleme (MRG) ile belirlendi. Böbrek fonksiyonları; serum kreatinin, tahmini glomerüler filtrasyon hızı (eGFH), spot idrar protein/kreatinin oranı (SPKO) ile belirlendi. Ekokardiyografi (EKO) ile sol ventrikül ejeksiyon fraksiyonu (SVEF), sol atrium çapı (SAÇ), SV end-diyastolik çapı (SVEDÇ), SV end-sistolik çapı (SVESÇ) hesaplandı. Ateroskleroz varlığı karotis arter intima-media kalınlığı (KA- IMK) ölçümü ile belirlendi. Bulgular: Kronik böbrek hastalığı (KBH) evresine göre hastaların 46(%53.5)’sı evre 1-2, 32(%37.2)’si evre 3-4 ve 8(%9.3)’i prediyaliz evre 5 ‘teydi. 56(%65.1) hasta hipertansifti. 36(%41.9) hastada SVH gelişimi saptandı. Evre 1-2 hastalarda, prediyaliz evre 5 hastalara göre eGFH daha yüksek; kreatinin, TBH, SPKO, SVKİ, KA-IMK daha düşüktü. TBH>1302mm 3 olanlarda, TBH ≤1302mm 3 olanlara göre; kreatinin (p=0.004), SVKİ (p=0.001), SVH (p=0.009), KA-IMK (p=0.022) yüksek, eGFH (p=0.006) düşüktü. Sonuç:ODPBH hastalarında artan TBH değerleri ve azalan böbrek fonksiyon testleri ile SVH ve ateroskleroz gelişimi arasında ilişki vardır.

🔖

Cite This Article

ÇOBAN, M., İNCİ, A., YILMAZ, Ü., SARIKYA, M., EROL, B., KILAR, Y., EREN, E., ASİLTÜRK, E. (2018). THE RELATIONSHIP BETWEEN RENAL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 22 - Sayı: 2, 49–57. https://ajindex.com/articles/196307

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Wong H, Vivian L, Weiler G, Filler G. Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 2004; 43(4): 624–8.
  2. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.Lancet 1994; 343(8901):824-7.
  3. Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the majör factor determining clinical outcomes. Clin J Am Soc Nephrol 2006; 1(1):148-57.
  4. Fick-Brosnahan G, Belz M, Mc Fann K, Johnson A, Schrier RW. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. Am J Kidney Dis 2002; 39(6): 1127–34.
  5. Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D,et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2012; 7(3):479-86.
  6. Sag S, Yildiz A, Gullulu S, Gungoren F, Ozdemir B, Cegilli E, et al. Early atherosclerosis in normotensive patients with autosomal dominant polycystic kidney disease: the relation between epicardial adipose tissue thickness and carotid intima- media thickness. Springerplus 2016;5:211. Martinez-Vea A, Bardaji A, Gutierrez C, Garcia C, Peralta C, Marcas L, et al. Exercise blood pressure,cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis 2004; 44(2):216-23.
  7. Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, et al. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6(10):2508-15.
  8. Bardaji A, Martinez-Vea A. Cardiac involvement in ADPKD: a hypertensive heart disease. Clin Nephrol 2001; 56(3):211- 20. Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW. Left ventricular hypertrophy in autosomal dominant polycyctic kidney disease. J Am Soc Nephrol 1997; 8(8):1292-7.
  9. Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kasikcioglu E, et al. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol 2008; 3(4):986-91. Schrier RW. Optimal care of autosomal dominant polycystic kidney disease patients.Nephrology (Carlton). 2006